Variable region sequence of specific anti-thiacloprid antibody and anti-thiacloprid recombinant overall-length antibody

A full-length antibody and variable region technology, applied in the field of genetic engineering, can solve the problems of differences between antibody batches, easy loss of effective genes, and inability of cell lines to produce effective antibodies, achieving high selectivity, high sensitivity, and guaranteed recognition. active effect

Active Publication Date: 2020-12-22
ZHEJIANG UNIV
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among the many recombinant antibody expression systems, the mammalian cell expression system can guide the correct folding of recombinant antibodies and provide accurate various post-translational processing and modification functions, so it can stably produce recombinant antibodies with the same activity as the parental antibody, which not only confirms The ac

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Variable region sequence of specific anti-thiacloprid antibody and anti-thiacloprid recombinant overall-length antibody
  • Variable region sequence of specific anti-thiacloprid antibody and anti-thiacloprid recombinant overall-length antibody
  • Variable region sequence of specific anti-thiacloprid antibody and anti-thiacloprid recombinant overall-length antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0022] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only It is a part of embodiments of the present invention, but not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative work should belong to the protection scope of the present invention. If there is no special description, the experimental methods in the embodiments are all for the conventional method.

[0023] The anti-thiamethoxam recombinant full-length antibody involved in the present invention includes a heavy chain constant region, a heavy chain variable region, a light chain constant region and a light chain variable region, and...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a variable region sequence of a specific anti-thiacloprid antibody. The amino acid sequence of a heavy chain variable region encoding gene is disclosed by SEQ ID NO: 2. The invention also discloses an anti-thiacloprid recombinant overall-length antibody, which comprises a heavy chain constant region, a heavy chain variable region, a light chain constant region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region encoding gene is disclosed by SEQ ID NO: 2. The invention also discloses an antibody expression plasmid. A sequence gene obtained by the invention is independently connected to expression carriers containing a heavy chain constant region gene and a light chain constant region gene, mammal cell of a double-plasmid system is adopted to obtain the recombinant overall-length antibody, the identification activity of a murine parent antibody is guaranteed, the anti-thiacloprid antibody can be stably produced ona large scale, and a reliable core reagent is provided for various immunoassay methods for detecting thiacloprid residues.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and in particular relates to the preparation of a variable region sequence of a specific anti-thiamethoxam antibody and a recombinant full-length antibody thereof. Background technique [0002] Neonicotinoid insecticides have become the fastest growing insecticides in the global market and are widely used in more than 120 countries around the world. This type of insecticide inhibits the acetylcholinesterase receptor of the central nervous system of the pest, blocks the normal conduction of the central nervous system of the pest, and causes the paralysis of the pest to death. etc. have a good control effect. Thiamethoxam (3-(2-chloro-1,3-thiazol-5-ylmethyl)-5-methyl-1,3,5-oxadiazin-4-ylidene(nitro)amine) is A second-generation neonicotinoid insecticide with a new structure has strong systemic and osmotic effects, so it will be distributed in various parts of the crop, and because of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K16/44C12N15/13C12N15/70
CPCC07K16/44C12N15/70C07K2317/56C07K2317/64C07K2317/92C07K2317/33
Inventor 郭逸蓉刘鹏琰赵颖郭源昊焦沙沙柳颖朱国念
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products